McNeill Jonathan
President and COO
McNeill Jonathan has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Sep 18, 2026.
On the most recent filing, McNeill Jonathan is listed as President and COO at CRESCENT BIOPHARMA, INC. Inside the rolling window, McNeill Jonathan reported no open-market purchases and 3 open-market sales totaling $447K in CBIO. The largest disclosed transaction in the window is a sale of 20,549 CBIO shares on Jun 22, 2026, worth $370K.
Companies traded
Other insiders at CBIO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$447K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has McNeill Jonathan made?
McNeill Jonathan has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does McNeill Jonathan trade?
McNeill Jonathan has filed SEC Form 4 disclosures for 1 company, including CBIO.
When was McNeill Jonathan's most recent SEC Form 4 filing?
McNeill Jonathan's most recent SEC Form 4 filing on Tracefour is dated Sep 18, 2026.
What is McNeill Jonathan's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, McNeill Jonathan is listed as President and COO.
What is McNeill Jonathan's total buy and sell value in the current window?
Inside the rolling retention window, McNeill Jonathan bought $0 and sold $447K based on SEC Form 4 filings.
What was McNeill Jonathan's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 20,549 CBIO shares on 2026-06-22, worth $370K, per SEC Form 4 filings.